Global Stem Cells Group today announced the opening of a new, Good Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group GMP facility is equipped with the most advanced technologies available, and is operated by a world-class team of qualified medical researchers and practitioners, experienced in administering stem cell protocols using highly manipulated cells.

GMPs are critical for cell therapy success. Understanding and incorporating GMP standards in clinical and pre-clinical research settings establishes a solid foundation on which to build clinical trials and to ensure the safety of biologic products. Good manufacturing practices ensure the safety and efficiency of stem cell products and the patients who receive them. The fundamentals of GMCs are also becoming an important part of the training received by academic researchers in the biotechnology industry, who are at the forefront of developing products for eventual clinical use.

Closed System 1

The Global Stem Cells Group GMP 1000 facility will begin receiving international patients in early January 2016.

The GSCG therapeutic center in Santiago—a separate facility from the CMP 1000—will begin seeing international patients as of Dec. 1, 2015 to make its stem cell therapies and facilities available to international patients as well.

For more information, visit the Global Stem Cells Group website, Email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.

About the Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.


Previous Post
Global Stem Cells Group Opens GMP 1000 Facility in Santiago, Chile
Next Post
Global Stem Cells Group, Inc. to Launch Two New Editions of “Diplomat in Cell Therapy and Tissue Engineering” Post-Graduate Diploma Program

Latest posts